Fierce Pharma

APRIL 26, 2024

After a negative phase 3 readout, Gilead Sciences is taking a $2.4 billion impairment charge on Trodelvy, which serves as the cornerstone of the company’s solid tumor ambition. | After a negative phase 3 readout, Gilead Sciences is taking a $2.4 billion impairment charge on the antibody-drug conjugate Trodelvy. With a busy year ahead across therapeutic areas, CEO Dan O'Day emphasized a "time of focused execution.

333

333

MedCity News

APRIL 26, 2024

Johns Hopkins Hospital teamed up with Healthy.io, a company that offers smartphone-based technology to improve wound care management for diabetic patients. The partners are conducting a 120-person study to measure the impact of the startup’s technology. The post Johns Hopkins Is Teaming Up With Healthy.io to Improve Diabetic Patients’ Wound Care appeared first on MedCity News.

Patients 126

Patients Management 126

Fierce Pharma

APRIL 26, 2024

Ten years after dipping its toes into the gene therapy pool in a licensing deal with Spark Therapeutics, Pfizer has gained FDA approval for the acquired treatment. | Ten years after dipping its toe into the gene therapy pool in a licensing deal with Spark Therapeutics, Pfizer has gained an FDA approval for the acquired treatment. The U.S. regulator has endorsed Beqvez for adults with the bleeding disorder hemophilia B.

FDA 325

FDA 325

MedCity News

APRIL 26, 2024

It’s time we move beyond BMI and adopt a holistic approach to truly gauge health. The post BMI: A Flawed Measure of Health appeared first on MedCity News.

Biopharma 122

Biopharma 122

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

APRIL 26, 2024

AbbVie’s immunology heirs Skyrizi and Rinvoq are proving booming growth to make up for once-king Humira’s continuous sales slide. | As Humira continues its sales free fall, newer Skyrizi is proving a worthy successor with nearly matching sales ahead of an upcoming FDA decision in ulcerative colitis.

Sales 305

Sales FDA 305

MedCity News

APRIL 26, 2024

Addressing preventable harm starts with breaking down the data silos that exist within the healthcare landscape and pulling disparate systems together through connected healthcare operations. The post Driving Safer Care for All with Connected Healthcare Operations appeared first on MedCity News.

Healthcare 119

Healthcare Healthcare Safety Patients 119

pharmaphorum

APRIL 26, 2024

Owlstone Medical has secured a $5 million equity investment and initial $1.5 million grant funding, committed by the Bill and Melinda Gates Foundation, for development of breath-based diagnostic solutions to improve outcomes in the developing world.

Medical 116

Medical 116

Fierce Pharma

APRIL 26, 2024

For the second time in four years, AbbVie’s Rinvoq (upadacitinib) has shown superior efficacy to Regeneron and Sanofi’s powerhouse Dupixent (dupilumab) in a head-to-head study in patients with atop | For the second time in four years, AbbVie’s Rinvoq (upadacitinib) has shown better skin clearance than Regeneron and Sanofi’s powerhouse Dupixent (dupilumab) in a head-to-head study in patients with atopic dermatitis (AD).

Patients 130

Patients 130

MedCity News

APRIL 26, 2024

The FDA has approved Beqvez, a Pfizer gene therapy developed for moderate-to-severe hemophilia B. The one-time treatment carries a $3.5 million price tag, the same as a CSL Behring gene therapy already available for treating the inherited bleeding disorder. The post Pfizer’s First Gene Therapy Approval Sets Up a Showdown With CSL in Hemophilia B appeared first on MedCity News.

FDA 112

FDA Biopharma Pharma 112

pharmaphorum

APRIL 26, 2024

In an ambitious move, Moderna has teamed up with OpenAI, the artificial intelligence company behind ChatGPT, to further integrate generative AI (GenAI) across its mRNA drug development and manufacturing operations.

Manufacturing 111

Manufacturing 111

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

European Pharmaceutical Review

APRIL 26, 2024

A paper has reported the first time that 3D printing has facilitated two active pharmaceutical ingredients (APIs) to be combined in the same formulation. This method enables the number of administrations of the drug evaluated to be minimised, the researchers found. The authors aimed to evaluate and compare the efficacy and acceptability of chewable 3D printed medicines containing citrulline, isoleucine, and valine alone or in combination.

Medicine 110

Medicine Pharmaceutical Pharmaceutical products Medical 110

pharmaphorum

APRIL 26, 2024

Chemists at ETH Zurich have developed a new computer process that enables the generation of active pharmaceutical ingredients at speed, based on a protein’s three-dimensional surface.

Pharmaceutical 105

Pharmaceutical 105

Pharmaceutical Commerce

APRIL 26, 2024

The latest news for pharma industry insiders.

Pharma 102

Pharma 102

PharmaTimes

APRIL 26, 2024

The paper identifies the roles of LARP4A and LARP4B in sarcoma and carcinoma cancers

98

98

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

European Pharmaceutical Review

APRIL 26, 2024

AbbVie has revealed positive topline results from the first head-to-head trial in atopic dermatitis assessing RINVOQ ® (upadacitinib) at a starting dose of 15mg daily versus DUPIXENT ® ( dupilumab ) at its labelled dose. The Phase IIIb/IV LEVEL UP study evaluated the efficacy and safety of these drugs in individuals 12 years old and older with moderate-to-severe atopic dermatitis.

Safety 98

Safety Patients Medical Medicine 98

PharmaTimes

APRIL 26, 2024

The new method could help to prevent severe side effects caused by enantiomer drugs

Side effects 88

Side effects Manufacturing 88

PharmaVoice

APRIL 26, 2024

Dr. Jeremy Levin, CEO of Ovid Therapeutics, explains how scientific advances have converged to create a new era of drug development potential.

80

80

MedCity News

APRIL 26, 2024

This rapidly growing field marries bioinformatics and pharmacology and represents a transformative new era of precision medicine and highly personalized treatments. The post Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine appeared first on MedCity News.

Medicine 75

Medicine Pharmacology 75

Advertisement

PharmaTech

APRIL 26, 2024

As breakthrough therapeutics in the pharma pipeline approach commercialization, pharmaceutical manufacturing facilities must evolve to meet demand.

Pharmaceutical manufacturing 72

Pharmaceutical manufacturing Manufacturing Pharma Pharmaceutical 72

MedCity News

APRIL 26, 2024

Check out news from Alpha Sophia, Handl Health, Alaffia Health, and Summer Health The post StartUPDATES: New Developments from Healthcare Startups appeared first on MedCity News.

Healthcare 64

Healthcare Healthcare 64

PharmaTech

APRIL 26, 2024

The collaboration will combine N4’s nanoparticle delivery system with SRI’s molecular guidance system.

Pharma 59

Pharma 59

Pharmacy Times

APRIL 26, 2024

On this month's episode Laura Gillespie, PharmD, discusses her paper “Impact of Pharmacist-Led Initiatives on Health Care–Associated Clostridioides difficile Rates.

55

55

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmExec

APRIL 26, 2024

In an interview with Pharm Exec Associate Editor Don Tracy, Howard Berman, Chairman, CEO, Coya Therapeutics offers a look at the organization's pipeline.

52

52

Pharmacy Times

APRIL 26, 2024

Tovorafenib is the first systemic therapy to be approved for the treatment of pediatric patients who have low-grade glioma with BRAF rearrangements or fusions.

Patients 52

Patients FDA 52

PharmaTech

APRIL 26, 2024

A tidal wave of questions floats the need for more upstream automation.

52

52

PharmExec

APRIL 26, 2024

Beqvez, a one-time gene therapy, offers hope to patients with moderate to severe hemophilia B who use regular factor IX prophylaxis, suffer severe hemorrhages, or recurrent serious bleeding.

FDA 52

FDA Patients 52

Advertisement

Distribution

Impetus Digital

APRIL 26, 2024

This is a guest article and does not necessarily reflect the views and values of Impetus Digital. As we continue to transition towards and rely more heavily on artificial intelligence (AI) as a practical, day-to-day tool, an increasing number of sectors are choosing to implement this futuristic technology. This is no truer than in the healthcare sector.

Healthcare Provider 52

Healthcare Provider Healthcare Healthcare Patients 52

PharmExec

APRIL 26, 2024

Approval update comes as a result of findings from Study 5310, which addressed Biktarvy’s pharmacokinetics, safety, and efficacy during pregnancy and postpartum periods in patients with HIV.

Safety 52

Safety FDA Patients 52

PM360

APRIL 26, 2024

Healthcare advertising rarely demonstrates that it knows how to reward customers for their time, or shows what a smart creative idea can do. We need a better approach. Making memorable creative isn’t easy but it is possible in healthcare. There are just certain must haves. The first must have is obviously a talent for creative. Creative talent is the love child of imagination and a sense of humor.

Healthcare 52

Healthcare Healthcare Media Sales goal 52

PharmExec

APRIL 26, 2024

In this Pharmaceutical Executive video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One, discusses what other tactics healthcare marketers can utilize to connect with diverse audiences on a deeper level

Marketing 52

Marketing Healthcare Healthcare Pharmaceutical 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales